MedPath
HSA Approval

OXYCODONE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 10MG/ML

SIN15996P

OXYCODONE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 10MG/ML

OXYCODONE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 10MG/ML

August 21, 2020

MEDIPHARM PTE LTD

MEDIPHARM PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDIPHARM PTE LTD
Licence HolderMEDIPHARM PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, SUBCUTANEOUS

Medical Information

N02AA05

oxycodone

Manufacturer Information

MEDIPHARM PTE LTD

CP Pharmaceuticals Limited

Active Ingredients

Oxycodone Hydrochloride

10.00 mg/mL

Oxycodone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OXYCODONE WOCKHARDT SOLUTION FOR INJECTION OR INFUSION 10MG/ML - HSA Approval | MedPath